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Abstract 
 
Background: National or local laws, norms or regulations (sometimes and in some 
countries) require medical providers to report notifiable diseases to public health 
authorities.  Reporting, however, is almost always incomplete. This is due to a variety 
of reasons, ranging from not recognizing the diseased to failures in the technical or 
administrative steps leading to the final official register in the disease notification 
system. The reported fraction varies from 9% to 99% and is strongly associated with the 
disease being reported.  
 
Methods: In this paper we propose a method to approximately estimate the full 
prevalence (and any other variable or parameter related to transmission intensity) of 
infectious diseases. The model assumes incomplete notification of incidence and allows 
the estimation of the non-notified number of infections and it is illustrated by the case of 
hepatitis C in Brazil. The method has the advantage that it can be corrected iteratively 
by comparing its findings with empirical results. 
 
Results: The application of the model for the case of hepatitis C in Brazil resulted in a 
prevalence of notified cases that varied between 163,902 and 169,382 cases; a 
prevalence of non-notified cases that varied between 1,433,638 and 1,446,771; and a 
total prevalence of infections that varied between 1,597,540 and 1,616,153 cases. 
 
Conclusions: We conclude that that the model proposed can be useful for estimation of 
the actual magnitude of endemic states of infectious diseases, particularly for those 
where the number of notified cases is only the tip of the iceberg. In addition, the method 
can be applied to other situations, such as the well known underreported incidence of 
criminality (for example rape), among others. 
 
 
Keywords: Hepatitis C; Mathematical Models; Notifications System Incidence; 
Prevalence. 
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Background 
 
Compulsory notifiable diseases (CNDs) are those diseases that should be compulsorily 
reported to Health Authorities as soon as suspected by the attending professional [1] 
(Roush et al., 1999). The notified cases then enter a database from which, among other 
things, it is possible to know the incidence (new cases per age, sex, risk factor, 
geographic location, etc, per period of time) of the disease. The availability of such 
information allows health authorities, in principle, to monitor and to plan controlling the 
disease, for example providing early warning of possible outbreaks [2] (MMWR, 1998). 
 
Almost 50 years ago, the World Health Organization's International Health Regulations 
1969 (IHR/69) already required disease reporting to the organization in order to help 
with its global surveillance and advisory role. These regulations were rather limited 
with a focus on reporting of only three main diseases: cholera, yellow fever and plague 
[3] (WHO, 1969). 
The revised International Health Regulations 2005 (IHR/2005), which entered into 
force on 15 June 2007, aims “to prevent, protect against, control and provide a public 
health response to the international spread of disease in ways that are commensurate 
with and restricted to public health risks, and which avoid unnecessary interference with 
international traffic and trade” [4] (WHO, 2005, p.4). 
The IHR (2005) includes new demands to participant countries, such as: "(a) a scope not 
limited to any specific disease or manner of transmission, but covering “illness or 
medical condition, irrespective of origin or source, that presents or could present 
significant harm to humans”; (b) State Party obligations to develop certain minimum 
core public health capacities; (c) obligations on State Parties to notify WHO of events 
that may constitute a public health emergency of international concern according to 
defined criteria; (d) provisions authorizing WHO to take into consideration unofficial 
reports of public health events and to obtain verification from State Parties concerning 
such events; (e) procedures for the determination by the Director-General of a “public 
health emergency of international concern” and issuance of corresponding temporary 
recommendations, after taking into account the views of an Emergency Committee; (f) 
protection of the human rights of persons and travellers; and (g) the establishment of 
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National IHR Focal Points and WHO IHR Contact Points for urgent communications 
between State Parties and the WHO" [4] (WHO, 2005, p.4).  
In spite of international, national or local laws, norms or regulations requiring medical 
providers to report notifiable diseases to public health authorities, reporting is almost 
always incomplete [5-10] (Doyle, 2002; Gibbons et al., 2014; Keramarou and Evans, 
2012; Rowe and Cowie, 2016; Gibney et al., 1991; Serra et al., 1999). This is due to a 
variety of reasons, ranging from not recognizing the diseased to failing in the technical 
and administrative steps leading to the final official report in the disease notification 
system. A recently published review [5] (Doyle et al., 2002), limited to published 
studies conducted in the United States between 1970 and 1999, quantitatively assessed 
infectious disease reporting completeness and found that reporting completeness varied 
from 9% to 99% and was strongly associated with the disease being reported. In another 
study [11] (Thacker et al., 1983), the mean reporting completeness for acquired 
immunodeficiency syndrome, sexually transmitted diseases, and tuberculosis as a group 
was significantly higher (79%) than for all other diseases combined (49%).  
 
Of particular concern are those chronic, mainly asymptomatic, infectious diseases that 
allow infected individuals to live for years or even decades without being recognized as 
so. These diseases can represent a heavy burden to the affected populations and pose 
significant risk to the international community. Perhaps the most dramatic examples of 
the latter include human immunodeficiency (HIV) and hepatitis C (HCV) viruses 
pandemics. In fact, these two infections have been labeled by WHO as the epidemics of 
the XXth and XXIth centuries, respectively [9], [12] (Mann, 1996; Gibney et al., 2016).  
 
One critical consequence of under-notification of such diseases is the fact that their 
prevalence estimates are frequently way underestimated, leading to miscalculation of 
their actual burden and making control efforts suboptimal [6] (Gibbons et al., 2014). 
 
In a previous paper [13] (Amaku et al., 2016) we assumed that the infection (HCV) was 
in steady-state. Then we proposed two methods to give a first rough estimate of the 
actual number of HCV infected individuals (prevalence) taking into account the yearly 
notification rate of newly reported infections (incidence of notification) and the size of 
the liver transplantation waiting list (LTWL) of patients with liver failure due to chronic 
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HCV infection [14] (Chaib et al., 2014). Both approaches, when applied to the Brazilian 
HCV situation converged to the same results, that is, the methods proposed reproduce 
both the prevalence of reported cases and the LTWL with reasonable accuracy. In that 
paper we show how to calculate the prevalence of people living with HCV in Brazil, 
which resulted in a value up to 8 times higher than the official reported number of cases 
[13] (Amaku et al., 2016).  
 
The present paper is an improvement of those techniques because, unlike in the 
previous paper mentioned above, now we do not assume steady state. Unfortunately, 
given the short period of time with data available (hepatitis notification became 
compulsory in Brazil only in 1999 [15] (MHB, 2000)), it cannot give more precise 
information on HCV prevalence than the one already provided by our previous study, 
but it illustrates the techniques that allow the prevalence estimation based on age and 
time of previous notifications, and that can be applied to any notifiable disease.  
 
This paper is organized as follows. In Section 2, we describe the variables that can be 
extracted from the governmental notification database, by using two mathematical 
models. In Section 2.1 we describe a continuous model, that is a model where the 
variables are assumed to be continuous functions of time and age. In Section 2.2 we 
describe a discrete model, in which the variables are assumed to have only integer 
values in time and age.  
 
Methods 
Formalism 
Continuous time and age model 
 
Assume we have an SIR type infection and let dataS ),( , dataI ),(  and dataR ),( be the 
number of individuals with age between daaa  and at time t  that are susceptible, 
infected and removed (or recovered), respectively. In addition, as mentioned in the 
Introduction, Public Health authorities demand that some diseases be compulsorily 
notifiable, that is they publish the number of diagnosed individuals per time unit for 
each age interval (incidence) in public databases. Therefore, we can divide the 
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prevalence of infected individuals into two classes: notified individuals, denoted 
dataI N ),( , and non-notified individuals, denoted dataI NN ),( . 
 
Let ),( ta be the so-called age and time-dependent force-of-infection (incidence 
density). Then: 
 
dadttaSta ),(),(                                                                                                     (1) 
 
is the number of susceptible individuals who get the infection when aged between 
daaa  and  during the time interval dt . Standard arguments allow us to write the 
following system of partial differential equations, known as Trucco-Von Foester 
equations in the literature (Trucco, 1965): 
 
𝜕𝑆(𝑎, 𝑡)
𝜕𝑡
+
𝜕𝑆(𝑎, 𝑡)
𝜕𝑎
= −𝜆(𝑎, 𝑡)𝑆(𝑎, 𝑡) − 𝜇(𝑎, 𝑡)𝑆(𝑎, 𝑡),                                                           
𝜕𝐼𝑁𝑁(𝑎, 𝑡)
𝜕𝑡
+
𝜕𝐼𝑁𝑁(𝑎, 𝑡)
𝜕𝑎
= 𝜆(𝑎, 𝑡)𝑆(𝑎, 𝑡)                                                                             (2)   
−(𝜇(𝑎, 𝑡) + 𝛼𝑁𝑁(𝑎, 𝑡) + 𝛾𝑁𝑁(𝑎, 𝑡))𝐼𝑁𝑁(𝑎, 𝑡) − 𝜅(𝑎, 𝑡)𝐼𝑁𝑁(𝑎, 𝑡), 
𝜕𝐼𝑁(𝑎, 𝑡)
𝜕𝑡
+
𝜕𝐼𝑁(𝑎, 𝑡)
𝜕𝑎
=  𝜅(𝑎, 𝑡)𝐼𝑁𝑁(𝑎, 𝑡) − (𝜇(𝑎, 𝑡) + 𝛼𝑁(𝑎, 𝑡) + 𝛾𝑁(𝑎, 𝑡))𝐼𝑁(𝑎, 𝑡),   
 
𝜕𝑅(𝑎, 𝑡)
𝜕𝑡
+
𝜕𝑅(𝑎, 𝑡)
𝜕𝑎
=  𝛾𝑁𝑁(𝑎, 𝑡)𝐼𝑁𝑁(𝑎, 𝑡) + 𝛾𝑁(𝑎, 𝑡)𝐼𝑁(𝑎, 𝑡) − 𝜇(𝑎, 𝑡)𝑅(𝑎, 𝑡),
 
 
where the meaning of the parameters is described in Table 1. 
 
Table 1. Parameters used in model (2).  
Parameter Meaning 
),( ta  Force of Infection 
),( ta  Natural Mortality Rate 
),( taNN  Disease-induced Mortality Rate for non-notified individuals* 
),( taN  Disease-induced Mortality Rate for notified individuals* 
),( taNN  Recovery Rate for non-notified individuals 
),( taN  Recovery Rate for notified individuals 
),( ta  Notification Rate 
              * Constructed as equal to 0.15/{1 + exp(−0.1(a − 57.31))} years−1 as in Amaku et al. (2016b). 
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The solution of system (2) can be obtained with the method of characteristics (Trucco, 
1965). However, for our purposes, it is better to solve the equation by following a 
cohort, as described in (Lopez et al., 2016).  
 
The solution of the equation for susceptible individuals is: 
 
𝑆(𝑎, 𝑡0 + 𝑎) = 𝑆(0, 𝑡0)𝑒𝑥𝑝 (− ∫ [𝜆(𝑠, 𝑡0 + 𝑠) + 𝜇(𝑠, 𝑡0 + 𝑠)]𝑑𝑠
𝑎
0
).                           (3)  
 
The solution for the equation for infected individuals is: 
 
𝐼𝑁𝑁(𝑎, 𝑡0 + 𝑎) = ∫ 𝜆(𝑠, 𝑡0 + 𝑠)
𝑎
0
𝑆(𝑠, 𝑡0 + 𝑠)                                                                               
𝑒𝑥𝑝(− ∫ [𝜇(𝑥, 𝑡0 + 𝑥) + 𝛾
𝑁𝑁(𝑥, 𝑡0 + 𝑥) + 𝛼
𝑁𝑁(𝑥, 𝑡0 + 𝑥) + 𝜅(𝑥, 𝑡0 + 𝑥)]𝑑𝑥
𝑎
𝑠
) 𝑑𝑠,  (4) 
𝐼𝑁(𝑎, 𝑡0 + 𝑎) = ∫ 𝜅(𝑠, 𝑡0 + 𝑠)
𝑎
0
𝐼𝑁𝑁(𝑠, 𝑡0 + 𝑠)                                                                             
                                𝑒𝑥𝑝(− ∫ [𝜇(𝑥, 𝑡0 + 𝑥) + 𝛾
𝑁(𝑥, 𝑡0 + 𝑥) + 𝛼
𝑁(𝑥, 𝑡0 + 𝑥)]𝑑𝑥
𝑎
𝑠
) 𝑑𝑠.   (5) 
 
Finally, the equation for the removed individuals is given by: 
𝑅(𝑎, 𝑡0 + 𝑎) = ∫ (𝛾
𝑁𝑁(𝑠, 𝑡0 + 𝑠)𝐼
𝑁𝑁(𝑠, 𝑡0 + 𝑠) +  𝛾
𝑁(𝑠, 𝑡0 + 𝑠)𝐼
𝑁(𝑠, 𝑡0 + 𝑠))
𝑎
0
               
                                                                                              𝑒𝑥𝑝(− ∫ [𝜇(𝑥, 𝑡0 + 𝑥)]𝑑𝑥
𝑎
𝑠
) 𝑑𝑠.   (6) 
 
Assuming steady state, the system (1) was solved by Amaku et al. [13] (2016) to 
calculate the prevalence of HCV in Brazil. The work that follows is an extension of the 
methods described there and its results are in accordance with the previous results for 
the cases where real data are available. 
 
Discrete time and age model 
 
In real life epidemics notification is discrete with the time and age units expressed in 
weeks, months or years. Hence, in order to apply the model to a real public health 
problem we discretized model (2), with time and age unit expressed in years. This 
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discretization has to be done carefully to use the maximum advantage of the data 
available. 
 
Calculating the prevalence INN*(A,ti) and IN*(A,ti) 
 
We assume a time discrete as follows: the time  is taken to be December 31 at 11:59 
pm of year ; A (a discrete integer variable) is the age of the individual, in whole years, 
at time ti. So the continuous age a is between A and A+1 years, including A but 
excluding A+1. 
 
Denote by INN*(A,ti) and I
N*(A,ti) respectively the number of non-notified and notified 
individuals aged A (exact age between A and A+1) at time ti. In the following the 
parameters and variables such as 𝜅𝐴,𝑡𝑖  and 𝜙𝐴,𝑡𝑖
𝑁𝑁  mean the corresponding 
functions 𝜅(𝑎, 𝑡𝑖) and 𝜙
𝑁𝑁(𝑎, 𝑡𝑖) calculated for a ∈ [A, A+1) and t ∈ (ti-1, ti]. 
 
The discretized versions of equations (4) and (5) are given by equations (7) and (8) 
below, which are approximations as explained in the Appendix. 
𝐼𝑁𝑁∗(𝐴, 𝑡𝑖) = 𝐼
𝑁𝑁∗(𝐴 − 1, 𝑡𝑖 − 1)𝑒𝑥𝑝 [−
1
2
(𝜅𝐴−1,𝑡𝑖 + 𝜅𝐴,𝑡𝑖 + 𝜙𝐴−1,𝑡𝑖
𝑁𝑁 + 𝜙𝐴,𝑡𝑖
𝑁𝑁)] 
                              +𝐼𝑁𝐶(𝐴, 𝑡𝑖),                                                                                      (7) 
where 𝐼𝑁𝐶(𝐴, 𝑡𝑖)is the new HCV cases occurring between times ti-1 and ti that are still 
alive, infectious and non-notified at time ti in the year cohort born between times ti-A-1 
and ti-A.  Here 𝜙𝑁𝑁(𝑎, 𝑡) = 𝜇(𝑎, 𝑡) + 𝛾𝑁𝑁(𝑎, 𝑡)+ 𝛼𝑁𝑁(𝑎, 𝑡). In equation (7), the term 
𝑒𝑥𝑝 [−
1
2
(𝜅𝐴−1,𝑡𝑖 + 𝜅𝐴,𝑡𝑖 + 𝜙𝐴−1,𝑡𝑖
𝑁𝑁 + 𝜙𝐴,𝑡𝑖
𝑁𝑁)] 
means the probability of not being removed from the non-notified class of individuals, 
either by natural death, disease-induced death, recovery or notification in the interval  
(ti-1,ti]. Equation (7) is very important because, as shown later in the paper, it allows the 
calculation of the true incidence from empirical data (see equation (12) below). 
 
Recurrence (7) can be solved by well known methods and the prevalence of notified and 
non-notified individuals can be estimated (see equations (13) and (14) below). 
  
Similarly, we can write: 
it
i
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𝐼𝑁∗(𝐴, 𝑡𝑖) = 𝐼
𝑁∗(𝐴 − 1, 𝑡𝑖 − 1)𝑒𝑥𝑝 [−
1
2
(𝜙𝐴−1,𝑡𝑖
𝑁 + 𝜙𝐴,𝑡𝑖
𝑁 )]                                                      
                                  +∫ 𝑁𝑂𝑇𝐼𝐹𝐼𝐶𝐴𝑇𝐼𝑂𝑁(𝑎, [𝑡𝑖 − 1, 𝑡𝑖])𝑑𝑎,
𝐴+1
𝐴
                                  (8) 
 
where 𝜙𝑁(𝑎, 𝑡) = 𝜇(𝑎, 𝑡) + 𝛾𝑁(𝑎, 𝑡)+ 𝛼𝑁(𝑎, 𝑡). The last term represents the 
notifications of HCV between times ti-1 and ti of individuals in the year cohort born in 
ti-A-1 to ti-A who are still in the notified class at time ti, i.e. 
 
∫ ∫ 𝜅(𝑎 − 1 + 𝑥, 𝑡𝑖 − 1 + 𝑥)𝐼
𝑁𝑁(𝑎 − 1 + 𝑥, 𝑡𝑖 − 1 + 𝑥)                                               
1
0
𝐴+1
𝐴
 
                                                         𝑒𝑥𝑝 [− ∫ 𝜙𝑁(𝑎 − 1 + 𝑧, 𝑡𝑖 − 1 + 𝑧)
1
𝑥
𝑑𝑧] 𝑑𝑥 𝑑𝑎, 
                                                   ≈  𝜅 (𝐴 +
1
2
, 𝑡𝑖) 𝐼
𝑁𝑁 (𝐴 +
1
2
, 𝑡𝑖) ≈ 𝜅(𝐴, 𝑡𝑖)𝐼
𝑁𝑁∗(𝐴, 𝑡𝑖),     (9) 
 
as the integration intervals are of length one and 𝑎 = 𝐴 +
1
2
, x=1 lies in both of them, as 
explained in the Appendix (equation (A5)). 
 
Equations (7) and (8) are almost useless as written. However, in the next section, we are 
going to show how to solve them using the notified cases in a particular setting, namely 
hepatitis C in Brazil. Using the notified incidences and good guesses for the mortality 
rates we can calculate any desired properties of the infected population. In the next 
section we calculate the prevalence of the disease. The calculation presented applies to 
any notifiable infectious disease. 
 
Example of Application: Hepatitis C 
 
In this section we exemplify the above theory by calculating the prevalence of hepatitis 
C (HCV), a flaviviral infection that afflicts close to 3% of the world population (WHO, 
2016), in Brazil. As mentioned in the Introduction, the great majority of infections with 
HCV, however, are not easily identified and, therefore, frequently non-notified. We use 
the Brazilian Ministry of Health official notification systems, called "Sistema 
Informação Nacional de Agravos de Notificação (National Information System of 
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Notifiable Diseases)" (SINAN, 2015), this data is denoted hereafter ),( taSINAN .  
Figure 1 shows the time and age variation in the reported number of HCV in Brazil. 
 
In fact, the actual number of reported HCV infections is available only from 2000 
onward. As we know from previous studies (Romano et al., 2010), HCV was introduced 
in Brazil in the later 1950s. We therefore constructed the number of reported with a 
sigmoidal decay backwards until 1932, as argued below. We used this artifice only to 
illustrate the model and these figures have little epidemiological significance, as argued 
below. We shall return to this point in the results section 4, where we explain this 
procedure in more detail. 
 
 
Figure 1. Time and Age variation of the reported number of HCV infections in Brazil, 
artificially constructed by extrapolating backwards until 1932. 
 
 
Estimating the total number of HCV infected individuals in Brazil 
 
We define SINAN(a,t) to be the density with respect to age a of the incidence of notified 
cases at time t. Hence SINAN(a,t) has dimensions (time)-2. As in Amaku et al. (2016) we 
assume that SINAN(a,t) is a fraction of the density with respect to age of non-notified 
cases: 
                                              SINAN(a,t) = 𝜅𝑎,𝑡𝐼
𝑁𝑁(𝑎, 𝑡).                                            (10) 
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We want to relate SINAN(a,t) to the SINAN database so we introduce SINAN*(A,ti) to 
denote the number of individuals aged A to A+1 at time ti who were notified to SINAN 
in the current year (ti-1,ti]. Now  
                                           SINAN*(A,ti) ≈ 𝜅𝐴,𝑡𝑖𝐼
𝑁𝑁∗(𝐴, 𝑡𝑖),                                        (11) 
 using equation (9). 
 
From (7) and (11) we can write down the fundamental equation for estimating the 
incidence: 
𝐼𝑁𝐶(𝐴, 𝑡𝑖) =
𝑆𝐼𝑁𝐴𝑁∗(𝐴, 𝑡𝑖)
𝜅𝐴,𝑡𝑖
                                                                                                             
                     − 
𝑆𝐼𝑁𝐴𝑁∗(𝐴 − 1, 𝑡𝑖−1)
𝜅𝐴−1,𝑡𝑖−1
exp (−
1
2
(𝜅𝐴−1,𝑡𝑖 + 𝜅𝐴,𝑡𝑖 + 𝜙𝐴−1,𝑡𝑖
𝑁𝑁 + 𝜙𝐴,𝑡𝑖
𝑁𝑁)). 
                                                                                                                                      (12) 
Note that, as observed in equation (12), the method consists of subtracting consecutive 
values of a diagonal of a matrix containing age in lines and time in columns. In some 
instances, however, it may happen that for certain ages and years the calculated 
incidence is negative. Our interpretation is that, for that particular age and time, the 
notified incidence was zero. When this happened in the actual calculation we assigned 
the value zero to the notification incidence.  
 
Therefore, INN*(A,ti) can be calculated for each age and time reported as 
𝐼𝑁𝑁∗(𝐴, 𝑡𝑖) = ∑ 𝐼𝑁𝐶(𝐴 − 𝑗, 𝑡𝑖 − 𝑗)
𝐴
𝑗=0
                                                                                              
𝑒𝑥𝑝 {−
1
2
∑(𝜅𝐴−1−𝑝,𝑡𝑖−𝑝 + 𝜅𝐴−𝑝,𝑡𝑖−𝑝 + 𝜙𝐴−1−𝑝,𝑡𝑖−𝑝
𝑁𝑁 + 𝜙𝐴−𝑝,𝑡𝑖−𝑝
𝑁𝑁 )
𝑗−1
𝑝=0
} . 
                                                                                                                                       (13) 
 
Similarly, for IN*(A,ti), we have: 
𝐼𝑁∗(𝐴, 𝑡𝑖) = ∑ 𝑆𝐼𝑁𝐴𝑁
∗(𝐴 − 𝑗, 𝑡𝑖 − 𝑗)
𝐴
𝑗=0
𝑒𝑥𝑝 {−
1
2
∑(𝜙𝐴−1−𝑝,𝑡𝑖−𝑝
𝑁 + 𝜙𝐴−𝑝,𝑡𝑖−𝑝
𝑁 )
𝑗−1
𝑝=0
}. 
                                                                                                                                       (14) 
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Figure 2 shows the calculation of 𝐼𝑁𝐶(𝐴, 𝑡𝑖) using equation (12) with the SINAN data 
as shown in Figure 1. 
 
The size of the Liver Transplantation Waiting List in Brazil 
 
It is known that a fraction of those individuals infected with HCV evolve to liver failure 
after many years of infection (Chaib and Massad, 2005). Let us denote those individuals 
diagnosed with liver failure of age A at time ti as ),( itALF  . These individuals have 
been necessarily diagnosed with HCV and, therefore, are a fraction of the notified 
infected 
 
 
Figure 2. Calculation of 𝑰𝑵𝑪(𝑨, 𝒕𝒊)from the SINAN data as shown in Figure 1. 
                                                                 
individuals ),(* i
N tAI . It is assumed that individuals develop liver failure after a 
minimum time interval , say 10 years. From equation (8) for ),(* i
N tAI   we obtain 
the equation for ),( itALF : 
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(15) 
where  A is a discretized function that decreases from  up until A , 
representing the rate at which infected (and notified) individuals of age A-τ develop 
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liver failure, and 1 A year. Summing up over all ages we obtain the size of 
, which is the total number of individuals with liver failure at time ti: 
.)(
2
1
exp),()(
max
min min
1
0
,,1
* 



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(16) 
Apart from those individuals who are transplanted (see below) corresponds to 
the Liver Transplantation Waiting List (LTWL). 
 
Let us now rewrite equation (16) considering transplantation. Let ),( ta be the 
transplantation rate of individuals of age a at time t. Then, equation (16) becomes 

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The number of transplants is then given by )( itTR  where
.)(
2
1
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),()(
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We take for
itA,
 a suitably truncated bell-shaped discrete function (Chaib and Massad, 
2005) with a maximum at 45 years of age for all . 
 
 
Results and Discussion 
One of our objectives is to calculate equations (13) and (14) in order to obtain the 
estimated prevalence of notified and non-notified HCV infections which sum up to total 
prevalence. Unfortunately, the data available are restricted to the period between 2000 
and 2012. In order to simulate a longer history of HCV infection in Brazil, we 
artificially constructed such a previous history by extrapolating backwards. First, we 
averaged the notified cases in the period between 2000 and 2012. Then, we fitted a 
sigmoidal-shaped curve representing the notified cases back for the period between 
1932 and 2000. We did that for all ages such that the age distribution of notified cases 
)( itLF
)( itLF
it
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was assumed fixed for all the extrapolated periods. We are well aware that HCV was 
probably introduced in Brazil in the 1950's and, therefore, this calculation is only an 
exercise to illustrate the method. 
 
In a previous paper (Amaku et al., 2016b), this extrapolation was done differently. We 
assumed the disease to be in steady state until 1932. The results of this previous 
calculation are therefore different from the ones presented in this paper. We shall 
elaborate on this later. To begin with, Figure 3 shows a preliminary result on this 
direction. The continuous line is the total prevalence extrapolating the data as if in 
steady state (Amaku et al., 2016b). The sigmoid dotted line is the total prevalence 
calculated assuming the artificially constructed notification as explained above. 
 
 
Figure 3. Comparison of the total prevalence calculated according to Amaku et al. (2016b) 
(continuous line) and assuming the notification as a sigmoidal extrapolation (dotted line). 
 
Results of the numerical calculations are summarized in Table 2. In it we compare the 
prevalence in 2012 of HCV infected individuals who have been reported to SINAN 
until 2012 with the outcomes of the model. In Figure 4 we also compare the size of the 
liver transplantation waiting list according to the official figures with the outcomes of 
the model. 
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The results called first method and second method in Table 2 were obtained using the 
following procedure (see Amaku et al. (2016) for details). First, we assumed that the 
infection was in steady state from 2004 to 2012 and averaged the reported incidence. 
This reported incidence was extrapolated backwards until 1932. It is therefore not 
surprising that the published number in Amaku et al. (2016) including the third and 
fourth columns of Table 2 are larger than the figures obtained in this paper. The 
difference represents up to a certain point the state of the infection prior to 2000 and 
from this point of view the results seem to be consistent with what was believed about 
the infection in Brazil. 
 
 
 
Table 2. Summary of the Results 
RESULTS 
Current 
Method 
First Method of 
Amaku et al. (2016) 
Second Method of 
Amaku et al. (2016) 
Prevalence of Notified HCV Infections 
 
163,902* 
 
169,382** 
 
- 
240,120# 
- 
227,074# 
Prevalence of Non-Notified HCV in Brazil 
 
1,433,638* 
 
1,446,771** 
 
 
- 
1,650,100# 
- 
1,632,300# 
Total Prevalence of HCV in Brazil 
 
1,597,540* 
 
1,616,153** 
 
 
- 
1,890,220# 
- 
1,859,374# 
*Using only the official SINAN period (2000-2012) assuming zero notification incidence for all years and ages from 
2000 backwards until 1932.  
** Calculated from real data (2000-2012) and extending the data backwards assuming a sigmoidal decay until 1932. 
# Taking the average number of cases reported annually to SINAN between 2004 and 2012, a period in which a 
steady state could be assumed. 
 
 
From the results of the current method expressed in Table 2 it is possible to observe that 
the difference between taking into account the constructed data backwards until 1932 
and the official SINAN period of 2000-2012, reflects the significant contribution of this 
period to both the SINAN and the total prevalence of HCV in Brazil. Note that the 
artificially constructed incidence will manifest itself for individuals older than 40 years. 
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Figure 4 shows the comparison between the actual size of the LTWL as in Chaib et al. 
(2014) and the result of the application of equation (17). 
 
 
This paper is an attempt to provide a method to estimate the actual number of infected 
individuals (and other parameters related to transmission) of compulsory notifiable 
infectious diseases from the officially notified number of cases. Considering that, in the 
great majority of cases, the number of notified cases represents only a small but variable 
fraction of the total number of infected individuals, a reliable method of estimating the 
latter from the former can represent an important tool for public health policies. 
Notwithstanding the recognized importance of under-notification of most chronic  
 
 
 
Figure 4. Comparison between the actual size of the LTWL as in Chaib et al. (2014) and 
the result of the application of equation (17). 
 
infections, the tools to deal with this information gap proposed so far are varied and, to 
the best of our knowledge, there is currently no consensus about which is or are the 
most appropriate (Doyle, 2002; Gibbons et al., 2014; Keramarou and Evans, 2012; 
Rowe and Cowie, 2016; Gibney et al., 1991; Serra et al., 1999). 
In a previous publication (Amaku et al., 2016), a continuous time-dependent model for 
the estimation of the total number of HCV infected individuals in Brazil was proposed. 
In that paper, we assumed a steady state for the period between 2004 and 2012, and we 
concluded that the non-notified to notified ratio in the number of infections was about 7 
to 1. The current work is an extension of that paper and we relaxed the steady state 
0
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assumption. To do a calculation for individuals with age up to 80 years, we artificially 
extended the official notification database backwards from the year 2000 back to 1932. 
This artificially constructed database was intended only to illustrate the method. In 
addition, we discretized the variables time and age both because the notification 
database presents the number of cases per year and because the discrete model is easier 
to be implemented, both mathematically and computationally, than the continuous age 
and time corresponding model. 
 
The method presented in this paper is applicable to any compulsory notifiable infectious 
disease provided that one has information about at least two end-points of the natural 
history of the disease of interest, or carrying out an alternative diagnostic test in a 
representative sample of the affected population. For instance, for the case of HCV, we 
used the number of notified cases and the size of the liver transplantation waiting list. 
For other diseases, in which one has only the number of notified cases, an alternative to 
the liver transplantation waiting list depends on the disease one is interested in. For 
instance, for the case of dengue in a sufficiently small region, an age-dependent 
seroprevalence profile of a properly designed sample of the population would be 
sufficient. For infections like HIV, in addition to the reported number of cases, a sample 
representing each group of risk should be used. 
 
The method demonstrated to be accurate in retrieving the number of infected individuals 
for the case of HCV and the results are in good accordance with the previous 
estimations by Amaku et al. (2016).  
 
In spite of its accuracy and simplicity, the method here presented has some important 
limitations that are worthwhile mentioning. Firstly, the model is data-greedy in the 
sense that a long time series of notified cases is necessary for the calculations. 
Secondly, the model has a large number of parameters whose values are not known with 
any precision for the great majority of cases. For example, as the model deals with long 
time series, demographic parameters such as the natural mortality rate are crucial for the 
calculations.  
 
Notwithstanding those limitations, the model has the advantage that it can predict 
quantities that can be iteratively used to improve it. For instance, for HCV the model 
18 
 
allows the calculation of the proportion of individuals that have the infection for years, 
that is the age of infection. If this can be checked from information from patients (e.g., 
blood transfusion time), the model can be improved immediately. This is thoroughly 
explained in Amaku et al. (2016). 
 
Conclusions 
We can conclude that the model proposed in this paper can be useful for estimation of 
the actual magnitude of endemic states of infectious diseases, particularly for those 
where the number of notified cases is only the tip of the iceberg. In addition, the method 
can be applied to other situations, such as the well known underreported incidence of 
criminality (for example rape), among others. 
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Appendix  
 
In this Appendix, we deduce the equation (7) from the main text. Let us define the 
function , which is a function that expresses the evolution of a cohort. 
Then  
𝑑
𝑑𝑥
[𝐼𝑁𝑁(𝑎 + 𝑥, 𝑡 + 𝑥)] = 𝜆(𝑎 + 𝑥, 𝑡 + 𝑥) 𝑆(𝑎 + 𝑥, 𝑡 + 𝑥)                                                       
                                                −[𝜅(𝑎 + 𝑥, 𝑡 + 𝑥) + 𝜙𝑁𝑁(𝑎 + 𝑥, 𝑡 + 𝑥)]𝐼𝑁𝑁(𝑎 + 𝑥, 𝑡 + 𝑥) , 
                                                                                                                                      (A1) 
where 𝜙𝑁𝑁(𝑎 + 𝑥, 𝑡 + 𝑥) = 𝜇(𝑎 + 𝑥, 𝑡 + 𝑥) + 𝛾𝑁𝑁(𝑎 + 𝑥, 𝑡 + 𝑥)+ 𝛼𝑁𝑁(𝑎 + 𝑥, 𝑡 + 𝑥). 
),( xtxaI NN 
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Multiplying both sides by 𝑒𝑥𝑝[∫ (𝜅(𝑎 + 𝑧, 𝑡 + 𝑧) + 𝜙𝑁𝑁(𝑎 + 𝑧, 𝑡 + 𝑧))𝑑𝑧
𝑥
0
], we have
 
𝑑
𝑑𝑥
[𝑒𝑥𝑝 [∫ (𝜅(𝑎 + 𝑧, 𝑡 + 𝑧) + 𝜙𝑁𝑁(𝑎 + 𝑧, 𝑡 + 𝑧))𝑑𝑧
𝑥
0
] 𝐼𝑁𝑁(𝑎 + 𝑥, 𝑡 + 𝑥)] = 
𝜆(𝑎 + 𝑥, 𝑡 + 𝑥) 𝑆(𝑎 + 𝑥, 𝑡 + 𝑥) 𝑒𝑥𝑝 [∫ (𝜅(𝑎 + 𝑧, 𝑡 + 𝑧) + 𝜙𝑁𝑁(𝑎 + 𝑧, 𝑡 + 𝑧))𝑑𝑧
𝑥
0
]. 
                                                                                                                                    (A2) 
So integrating we deduce that 
𝐼𝑁𝑁(𝑎, 𝑡) =  𝐼𝑁𝑁(𝑎 − 1, 𝑡 − 1)                                                                                          (A3) 
                     𝑒𝑥𝑝 [− ∫ {𝜅(𝑎 − 1 + 𝑧, 𝑡 − 1 + 𝑧) + 𝜙𝑁𝑁(𝑎 − 1 + 𝑧, 𝑡 − 1 + 𝑧)}𝑑𝑧
1
0
] 
                     +∫ 𝜆
1
0
(𝑎 − 1 + 𝑥, 𝑡 − 1 + 𝑥)𝑆(𝑎 − 1 + 𝑥, 𝑡 − 1 + 𝑥) 
                         𝑒𝑥𝑝 [− ∫ {𝜅(𝑎 − 1 + 𝑧, 𝑡 − 1 + 𝑧) + 𝜙𝑁𝑁(𝑎 − 1 + 𝑧, 𝑡 − 1 + 𝑧)}𝑑𝑧
1
𝑥
] 𝑑𝑥. 
The first term corresponds to non-notified individuals ages a-1 at time t-1 who remain 
infectious and non-notified at time t (when their age is a). The second term which we 
denote 
                                                 INCIDENCE(a,(t-1,t]) 
is the density with respect to age a of the incidence of HCV in the cohort of individuals 
born at time t-a which occurs in the time interval (t-1,t) and is still infectious and not 
notified at time t.  
 
Now, INN*(A,ti), the absolute number of infectious non-notified individuals of age in the 
interval [A,A+1) at time ti,  
                                                                  = ∫ 𝐼𝑁𝑁(𝑎, 𝑡𝑖)𝑑𝑎,
𝐴+1
𝐴
                                         (A4) 
                                                                  ≈ 𝐼𝑁𝑁 (𝐴 +
1
2
, 𝑡𝑖)                                               (A5) 
taking the midpoint as an approximation. 
 
Now from (A3) and (A4) 
INN*(A,ti)  =∫ 𝐼𝑁𝑁(𝑎 − 1, 𝑡𝑖 − 1)
𝐴+1
𝐴
 
                   𝑒𝑥𝑝 [− ∫ {𝜅(𝑎 − 1 + 𝑧, 𝑡𝑖 − 1 + 𝑧) + 𝜙
𝑁𝑁(𝑎 − 1 + 𝑧, 𝑡𝑖 − 1 + 𝑧)}𝑑𝑧
1
0
] 𝑑𝑎 
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                                 +∫ 𝐼𝑁𝐶𝐼𝐷𝐸𝑁𝐶𝐸(𝑎, [𝑡𝑖 − 1, 𝑡𝑖])𝑑𝑎.  
𝐴+1
𝐴
                                          (A6) 
The last term in (A6), which we shall denote INC(A,ti), represents the incidence 
between times ti-1 and ti of HCV that is still infectious and not notified at time ti, in the 
cohort born between times ti-A-1 and ti-A. In the first term in (A6) again for the a-
integration we take a=A+
1
2
 as an approximation.  
𝐼𝑁𝑁∗(𝐴, 𝑡𝑖) = 𝐼
𝑁𝑁 (𝐴 −
1
2
, 𝑡𝑖 − 1)                                                                                                   
                        𝑒𝑥𝑝 [− ∫ {𝜅 (𝐴 −
1
2
+ 𝑧, 𝑡𝑖 − 1 + 𝑧) + 𝜙
𝑁𝑁 (𝐴 −
1
2
+ 𝑧, 𝑡𝑖 − 1 + 𝑧)} 𝑑𝑧
1
0
] 
                                                                                                                         +INC(A,ti). 
              = 𝐼𝑁𝑁 (𝐴 −
1
2
, 𝑡𝑖 − 1)                                                                                              
                  𝑒𝑥𝑝 [− ∫ {𝜅 (𝐴 −
1
2
+ 𝑧, 𝑡𝑖) + 𝜙
𝑁𝑁 (𝐴 −
1
2
+ 𝑧, 𝑡𝑖)} 𝑑𝑧
1
0
] + 𝐼𝑁𝐶(𝐴, 𝑡𝑖), 
as 𝜅 (𝐴 −
1
2
+ 𝑧, 𝑡) + 𝜙𝑁𝑁 (𝐴 −
1
2
+ 𝑧, 𝑡) is the same for 𝑡 ∈ (𝑡𝑖 − 1, 𝑡𝑖].  
                        ≈ 𝐼𝑁𝑁∗(𝐴 − 1, 𝑡𝑖 − 1)𝑒𝑥𝑝 [−
1
2
(𝜅𝐴−1,𝑡𝑖 + 𝜅𝐴,𝑡𝑖 + 𝜙
𝑁𝑁
𝐴−1,𝑡𝑖
+ 𝜙𝑁𝑁
𝐴,𝑡𝑖
)] 
                                                                                                                         +INC(A,ti). 
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